Human Study on Self-management and Quality of Life in People with MS
In a study involving 55 people with MS, participants reported improvements in self-management, self-efficacy, and quality of life. The groups participating in a 4-day program and an MS institute showed particularly strong gains compared to those in standard online care after one month.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Demonstrated in people
- Mechanism
- Not reported
- Evidence strength
- Limited
- Outcome
- Positive
Why it matters
These findings suggest that intensive and integrated care approaches for MS might lead to better outcomes in quality of life and self-management skills than standard care.
What this does not prove
The study had a small sample size, faced pandemic-related challenges, and one group had limited clinical data. Thus, results may not be widely applicable.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Interventional
- Participants / samples
- 55 · basis not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-07-20
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- People with MS
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceOutcomes of Comprehensive Multiple Sclerosis Care: A Pilot Comparison of Intensive, Integrated, and Usual Care Approaches. ↗DOI: 10.7224/1537-2073.2024-101
Supporting passages (11)
peer reviewedPublication types: Journal Article
study designThis study was conducted at a nonprofit rehabilitation center.
subjectsParticipants were people with MS who (1) were in a 4-day comprehensive MS program (4Day; n = 24), (2) were receiving care in an MS institute (MSI; n = 10), or (3) were members of an online patient research platform (iConquerMS; iCMS; n = 21).
sample sizeParticipants were people with MS who (1) were in a 4-day comprehensive MS program (4Day; n = 24), (2) were receiving care in an MS institute (MSI; n = 10), or (3) were members of an online patient research platform (iConquerMS; iCMS; n = 21).
primary endpointThe 4Day and MSI groups had greater gains in self-management, self-efficacy, and quality of life, particularly at 1 month, compared with the iCMS group.
findingsAll groups showed improvements across most outcomes at 1 and 6 months. The 4Day and MSI groups had greater gains in self-management, self-efficacy, and quality of life, particularly at 1 month, compared with the iCMS group.
limitationsFurther research is needed due to small sample sizes, pandemic-related challenges, and limited clinical data for one group.
populationParticipants were people with MS who (1) were in a 4-day comprehensive MS program (4Day; n = 24), (2) were receiving care in an MS institute (MSI; n = 10), or (3) were members of an online patient research platform (iConquerMS; iCMS; n = 21).
outcomeCONCLUSIONS: Comprehensive MS care, whether delivered intensively over 4 days or through an integrated outpatient program, may enhance self-efficacy and quality of life more effectively than standard care alone.
human efficacyCONCLUSIONS: Comprehensive MS care, whether delivered intensively over 4 days or through an integrated outpatient program, may enhance self-efficacy and quality of life more effectively than standard care alone.
publication datePublication date: 2026-07-20
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.